Ligand validation:6J53

AMP: ADENOSINE MONOPHOSPHATE

AMP is a Ligand Of Interest in 6J53 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6J53_AMP_B_201	95%	45%	0.067	0.971	0.88	1.23	1	3	1	0	100%	1
5ED3_AMP_B_201	98%	49%	0.055	0.975	0.86	1.1	1	1	0	0	100%	1
3TW2_AMP_A_127	96%	33%	0.058	0.969	1.02	1.62	1	3	0	0	100%	1
6J58_AMP_B_201	95%	46%	0.065	0.967	0.89	1.19	1	2	0	0	100%	1
5ED6_AMP_B_201	79%	43%	0.105	0.949	0.86	1.35	1	5	0	0	100%	1
5KLZ_AMP_B_201	75%	44%	0.117	0.95	0.92	1.23	2	2	0	0	100%	1
3LOQ_AMP_A_271	100%	45%	0.039	0.987	0.82	1.3	-	2	2	0	100%	1
7SNB_AMP_A_303	100%	55%	0.045	0.993	0.75	0.98	-	1	0	0	100%	0.783
3FWZ_AMP_B_601	100%	32%	0.037	0.984	1.15	1.55	2	4	0	0	100%	1
4RDH_AMP_C_301	100%	23%	0.039	0.983	1.37	1.79	3	6	0	0	100%	1
3CLT_AMP_C_1262	100%	40%	0.046	0.987	0.91	1.4	1	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.